Insider Stock Trading History of Kaye Randall


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kaye Randall since year 2005. The trader's CIK number is 1350416. At the time of this reporting, Kaye Randall is the Chief Medical Officer of Axsome Therapeutics, Inc. . (stock ticker symbol AXSM). See this page for all insider trading activities at Axsome Therapeutics, Inc. .

Note that in the past Kaye Randall also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Kaye Randall since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-12-23 AXSM Axsome Therapeutics, Inc. Buy 1,000 9.03 9,026
2011-09-09 AVNR Avanir Pharmaceuticals Sale 100,000 2.75 275,000
2011-01-05 AVNR Avanir Pharmaceuticals Sale 10,000 4.05 40,500
2010-12-06 AVNR Avanir Pharmaceuticals Sale 10,000 3.80 38,000
2010-11-05 AVNR Avanir Pharmaceuticals Sale 10,000 4.76 47,560
2010-10-05 AVNR Avanir Pharmaceuticals Sale 10,000 3.23 32,270
2010-09-07 AVNR Avanir Pharmaceuticals Sale 10,000 2.70 27,030
2010-08-18 AVNR Avanir Pharmaceuticals Sale 35,000 3.08 107,660
2010-08-05 AVNR Avanir Pharmaceuticals Sale 10,000 3.28 32,800
2010-07-07 AVNR Avanir Pharmaceuticals Sale 10,000 3.02 30,200
2010-06-07 AVNR Avanir Pharmaceuticals Sale 50,000 2.38 119,100
2009-09-11 AVNR Avanir Pharmaceuticals Buy 2,000 2.18 4,360
2009-09-15 AVNR Avanir Pharmaceuticals Sale 2,000 2.10 4,200
2009-02-23 AVNR Avanir Pharmaceuticals Buy 10,000 .43 4,260
2006-05-08 AVNR Avanir Pharmaceuticals Option Ex 12,500 .04 500
2006-05-26 AVNR Avanir Pharmaceuticals Buy 2,500 9.96 24,892

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kaye Randall (Chief Medical Officer of Axsome Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.